Program Book Table of Contents

Program Book Table of contents

Welcome 3 Practical information 5 Organizing Committee 6 Fellows 6 Scientific Committee 7 Program 8 Capacity-building sessions 14 Symposiums 15 Faculty 17 Acknowledgments 35 Exhibitors 37 Notes 39

2 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Welcome

Dear Delegate,

We are delighted to welcome you to the Asia-Pacific AIDS & Co-infections Conference (APACC) 2020, the first-ever virtual APACC.

APACC provides a much-needed scientific platform that focuses on the developments, issues, and needs around HIV and co-infections in the Asia- Pacific region. Researchers have the opportunity to present and discuss Mark Boyd the latest developments and are provided with opportunities to interact, BA, BM, BS, DCTH&H, network, and form collaborations. Respected international experts integrate MHID, MD, FRACP science and clinical practice through state-of-the-art lectures, symposia, Lyell McEwin Hospital, and roundtable discussions in order to discuss best practices and advise on University of Adelaide, how treatment guidelines can be implemented. This year’s program features Australia plenary sessions, parallel sessions, capacity-building sessions, oral abstract presentations, poster presentations, virtual guided poster walks, and a virtual exhibition.

This meeting offers a unique opportunity for regional clinicians, researchers, and representatives of the pharmaceutical industry to meet, learn, and share knowledge.

We look forward to a productive and inspiring program. Patrick Chung-Ki Li Best regards, MBBS, FHKCP, FHKAM, FRCP Conference Chairs 2020 Hong Kong Sanatorium and Hospital, Hong Kong

Nittaya Phanuphak MD, PhD Institute of HIV Research and Innovation, Thailand

3 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Needs statement

In the Asian-Pacific region, there are 5.9 million of people Among people living with HIV, there is also a high living with HIV. With only 54% receiving antiretroviral prevalence and incidence of viral hepatitis. Additionally, therapy (ART), a considerable gap in the HIV testing and re-infection rates following HCV cure are relatively high treatment cascade is highlighted1. HIV incidence has in co-infected persons4. Region-specific distribution of slightly decreased in the region, but the response to the HCV genotypes and way of transmission are important HIV epidemic is highly uneven among various countries considerations to predict responses to new therapies, in the region. For instance, China, Philippines, Pakistan, highlighting a need for an educational program that Bangladesh, and Afghanistan have witnessed an increase reflects on region-specific aspects of epidemics, national in new infections in the last decade. Importantly, in policies, guidelines, and societal context. China, the epidemic pattern has shifted and the highest increase in new infections is observed in men who have Given the significant health and economic burden posed sex with men (MSM), whereas intravenous drug users by HIV and co-infections in the Asia-Pacific region and were previously the most affected key population2. the continuing development of novel therapeutic options, A similar trend is showcased in Thailand, Indonesia, there is a sustained need to educate future generations and Malaysia, underlining the importance of adjusting of the medical community engaged in providing clinical prevention strategies accordingly and effectively care to people infected with HIV. To that end, the Asia implementing pre-exposure prophylaxis (PrEP). This is Pacific AIDS & Co-infections Conference (APACC) strongly reflected in Australia where a significant decrease in new encourages the participation of young investigators by infections among MSM over the last few years has been financially supporting their attendance and promoting attributed to PrEP3. Although Thailand and Malaysia their work through abstract-driven sessions and guided notably eliminated mother-to-child-transmission (MTCT), poster tours and, thus, facilitating their interaction with the whole region still experiences a high MTCT rate of inspirational leaders in the field. 21% on average1. At least 75% of new HIV infections in the region occur amongst key populations, highlighting the need for legal reforms and other initiatives to reduce the discrimination and stigma affecting people living with HIV. Thailand orchestrated remarkable efforts to reduce social stigma and discrimination, guided by national policies and community involvement and this Meeting objectives serves as a great example for the region. This meeting aims to: South-East Asia and the Western Pacific contribute • Promote dissemination and successful to about 60% of the total tuberculosis (TB) cases translation of new knowledge on HIV and worldwide3. Even though a relatively small proportion co-infections in a neutral environment (5–10%) of people infected with M. tuberculosis will • Foster new and lasting cross-disciplinary develop the disease during their lifetime, the probability partnerships and collaborations between of this greatly increases in cases of HIV co-infection. This researchers in HIV, hepatitis, and tuberculosis, is a major problem in Africa, and in the Asia-Pacific region policymakers, NGOs, and other stakeholders in including China, India, Myanmar, Thailand, and Indonesia, order to improve knowledge sharing, with the which are high-burden countries where collective action end goal of improving health and the quality of is required to reduce TB/HIV co-infection rates. Thus, life within the aging HIV/AIDS population promoting the implementation of the WHO strategy • Attract, showcase, and retain new, early “Three Is of HIV/TB”, consisting of Intensified case finding, career, and underrepresented investigators in Isoniazid preventive therapy, and Infection control in these multidisciplinary areas of research and clinical settings, within the region is of great importance. translate novel findings into clinical practice

References: 1. Global Aids Update 2019. Communities At The Centre. 3. Global Tuberculosis Report 2019. World Health Organization (WHO), 2019. The Joint United Nations Programme on HIV/AIDS (UNAIDS), 2019. 4. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J 2. Zheng S. The growing threat of China’s HIV epidemic. Lancet 2018; 3. Hepatol. 2006;44(SUPPL. 1):6-9.

4 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Practical information

Abstracts Feedback forms Accepted abstracts are published in Reviews in Antiviral Your feedback is very valuable to us and enables us Therapy & Infectious Diseases, Volume 2020_6. to further improve this meeting. An electronic session survey form will be available on your screen at the end APACC virtual platform of each session. An online evaluation form will be sent APACC 2020 will be hosted on https://apacc2020.live/ by email at the end of the conference.

All registered participants are provided with personal Presentations and webcasts login credentials to access the congress portal during Provided with the author’s permission, videos along the event dates and 3 weeks following the closure of with the PDF presentations will be accessible as the event. If you do not receive the information please enduring materials on the virtual event platform until 7 contact the Conference Secretariat at info@virology- November 2020. All materials will be moved to education.com. AcademicMedicalEducation.com after 7 November.

Certificate of attendance Posters A Certificate of attendance will be sent by e-mail once Posters are accessbile in the e-Poster Area on the you complete the post-event survey. congress portal. Posters can be downloaded to your e-Conference bag. Conference Secretariat The conference organizers can be contacted for all Speakers questions concerning the logistics of the event. You Presenters and session chairs will receive a separate can submit technical inquiries to the Help Desk on set of login details for the session(s) they are involved the virtual platform or contact us at info@virology- in. Please log on at least 30 minutes before the session education.com for program-related questions during time. the event hours.

Win special prizes APACC 2020 organizes social media campaigns and treasure hunt games during the conference dates. Winners will receive special gifts such as an APACC 2020 conference bag, drink bottle, and free registration for APACC 2021. More instructions are described in the daily APACC notifications. Do not miss these opportunities.

e-Conference bag Electronic conference materials such as the program book and the abstract book can be found in the Disclaimer: This conference aims to offer participants the opportunity to share information. The Organizing Secretariat e-conference bag on the congress of this conference, Virology Education, cannot accept portal. Participants can also add any liability for the scientific content of the sessions or for e-posters, brochures, contacts to any claims which may result from the use of information or publications from this conference. Virology Education the bag, and download everything disclaims all liability for injuries or losses of whatever nature to their device at the event. incurred by individuals attending the conference.

5 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Organizing Committee

Charles Boucher Patrick Chung-Ki Li Jonathan Schapiro MBBS, FHKCP, FHKAM, FRCP MD, PhD MD Hong Kong Sanatorium Sheba Medical Centre, Erasmus Medical Centre, and Hospital, Israel the Netherlands Hong Kong

Mark Boyd BA, BM, BS, DCTH&H, MHID, MD, Nicholas Paton Annette Sohn FRACP MD, FRCP MD Lyell McEwin Hospital, National University of Singapore, TREAT Asia, University of Adelaide, Singapore Thailand Australia

Thuy Le MD, DPhil Nittaya Phanuphak Joseph Tucker Duke University, MD, PhD MD, PhD, AM USA Institute of HIV Research and University of North Carolina Oxford University Clinical Innovation, School of Medicine, Research Unit Thailand USA Vietnam

Sharon Lewin FRACP, PhD, FAAHMS Jürgen Rockstroh MD Doherty Institute for Infection and Immunity, University of University of Bonn, Melbourne, Germany Australia

Fellows

Phillip Yin Cheung Chan MBChB, MRCP, FHKCP, FHKAM Tavitiya Sudjaritruk Fan Yang Hong Kong University of Science PhD, MSc and Technology, MD, ScM, PhD University of North Carolina Hong Kong Chiang Mai University, at Chapel Hill, Thailand Institute of HIV Research and China Innovation, Thailand

6 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Scientific Committee

Zhiwei Chen, PhD, DVM The University of Hong Kong, Hong Kong

Jun Yong Choi, MD, PhD Severance Hospital, Yonsei University College of Medicine, South Korea

Ishwar Gilada, MD, DDV, FCPS AIDS Society of India, India

Chien-Ching Hung, MD, PhD National Taiwan University Hospital, Taiwan

Thana Khawcharoenporn, MD, MSc Thammasat University, Thailand

Saye Khoo, MD, PhD University of Liverpool, UK

Eugène Kroon, MD Institute of HIV Research and Innovation, Thailand

N. Kumarasamy, MD, PhD VHS Infectious Diseases Medical Centre, India

Man-Po Lee, MBBS, MSc, FHKCP, FHKAM, FRCP Queen Elizabeth Hospital, Hong Kong

Linghua Li, MD, PhD Guangzhou Eighth People’s Hospital, China

Seng Gee Lim, MBBS, FRACP, FRCP, MD National University of Singapore, Singapore

Hsi-Hsun Lin, MD, PhD Taipei Veterans General Hospital, Taiwan

Hongzhou Lu, MD, PhD Shanghai Public Health Clinical Center, Fudan University, China

Grace Chung-Yan Lui, MBChB, FHKCP, FHKAM The Chinese University of Hong Kong, Hong Kong

Shinichi Oka, MD, PhD National Center for Global Health and Medicine, Japan

Praphan Phanuphak, MD, PhD Institute of HIV Research and Innovation, Thailand

Reena Rajasuriar, MPharm, PhD University of Malaya, Malaysia

Kiat Ruxrungtham, MD Chulalongkorn University, Thailand

Akifumi Takaori-Kondo, MD, PhD Kyoto University, Japan

Owen Tak-Yin Tsang, MBChB, MRCP, FHKCP, Hospital Authority Infectious Disease Centre, Princess Margaret Hospital, Hong Kong FHKAM, MTH, DTM&H, LSHTM, FRCP

Rudi Wisaksana, MD, PhD Padjadjaran University, Hasan Sadikin General Hospital, Indonesia

Evy Yunihastuti, MD, PhD Faculty of Medicine University of Indonesia, HIV Integrated Clinic Cipto Mangunkusumo Hospital, Indonesia

Fujie Zhang, MD, PhD Beijing Ditan Hospital, Capital Medical University, China

7 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Program

Thursday, 15 October Bangkok time 14:00 h Opening of the Conference Opening Words Adeeba Kamarulzaman, MBBS, FRACP, FAMM, FASc, HonLLD Monash, DPMP President of IAS Welcome Remarks Nittaya Phanuphak, MD, PhD Conference Chair PL-1 Opening Session: 14:00-15:15 h Chairs: Nittaya Phanuphak, Mark Boyd, Patrick Li PLENARY ROOM 14:10 h What Will It Take to End AIDS in Asia Adeeba Kamarulzaman, MBBS, FRACP, FAMM, FASc, HonLLD Monash, DPMP University of Malaya, Malaysia 14:30 h No Pain, No Gain: Crisis, Resilience, and Winning Trust from SARS to COVID-19 Response in Taiwan Yi-Chun Lo, MD Taiwan CDC, Taiwan 14:50 h Discussion 15:15 h Break

15:30-16:30 h ViiV-supported Symposium: Putting the Person Back into Person-Centered Care and Treatment PLENARY ROOM

PA-1: Infectious Diseases Stigma: From Theory to Action PA-2: HIV Prevention 16:30-17:30 h Chairs: Joseph Tucker & Mark Nelson 16:30-17:30 h Chairs: Iskandar Azwa & Thana Khawcharoenporn PLENARY ROOM BREAKOUT ROOM 16:30 h Crowdsourcing to Decrease Hepatitis Stigma 16:30 h HIV Incidence and Sexual Behaviors Among Jingjing Li, MA Men Who Have Sex With Men Using Geosocial Social Entrepreneurship to Spur Health (SESH), Networking Smartphone Application in China Beijing, China: an Open Cohort Study (#O_01) Minying Zhang 16:45 h Addressing Stigma Against TB: From Theory to Action 16:40 h High PrEP Awareness and Intention to Use but Aamir Khan, MD, PhD Suboptimal Uptake Among Hornet Users in IRD, Singapore the Asia-Pacific (#O_02) Heather-Marie Schmidt 17:00 h Key Population-led Health Services to Combat Transgender Stigma 16:50 h Is risk Compensation Real? The Effect of Rena Janamnuaysook, MBA Perceived Level of HIV Transmission Risk on Institute of HIV Research and Innovation, Thailand Risk Behavior in an Open-label Pilot PrEP- based Intervention in Men Who Have Sex With 17:15 h Discucussion Men in Malaysia (#O_03) Kelsey A. Rankin 17:00 h Situational Analysis of HIV Pre-exposure Prophylaxis Among Gay Men, Other Men Who Have Sex With Men and Transgender Women in Myanmar (#O_04) Aung Than Oo 17:10 h PrEP or Condoms, or Both? Insights on Risk Compensation Through a Discrete Choice Experiment on PrEP Preferences Among Gay, Bisexual, and Other Men Who Have Sex With Men (#O_05) Rayner Kay Jin Tan 17:20 h Discussion

17:30 h Break

8 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Program

Thursday, 15 October

Bangkok time

18:00-19:00 h Capacity-building Session 1: Creating “Super” Models: a Biostatistics Workshop Stephen Kerr, Sirinya Teeraananchai, Fan Yang PLENARY ROOM

19:00 h Break

19:15-20:15 h Capacity-building Session 2: JIAS Scientific Writing Workshop: How to Write and Submit a Research Manuscript Kenneth Mayer, Tavitiya Sudjaritruk PLENARY ROOM

20:15 h Break

20:30-21:30 Capacity-building Session 3: Love at First Sight: Crafting Appealing Infographics Joseph Tucker, Krittaporn Termvanich PLENARY ROOM

21:30 h End of Day 1

9 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Program

Friday, 16 October Bangkok time

PT-1: Empowering Healthcare Provider PT-2: Impact of COVID-19 Among People Living With HIV in Asia 13:00-13:30 h Moderator: Patrick Li 13:00-13:30 h Moderator: Phillip Chan PLENARY ROOM BREAKOUT ROOM Poster #: P_45, P_65, P_67 Poster #: P_32, P_33, P_68, P_69

13:30 h Break

Roundtable Discussion: COVID-19 & HIV 14:00-15:15 h Moderator: Adeeba Kamarulzaman PLENARY ROOM Linghua Li, MD, PhD Junko Tanuma, MD Bum Sik Chin, MD, PhD Guangzhou Eighth People’s National Center for Global Health National Medical Center, Hospital, China and Medicine, Japan South Korea Yi-Chun Lo, MD Thanyawee Puthanakit, MD Tanat Chinbunchorn, MD Taiwan CDC, Chulalongkorn University, Institute of HIV Research and Taiwan Thailand Innovation, Thailand 15:15 h Break

15:30-16:30 h Gilead-supported Symposium HIV Management During COVID-19: What to Do & What Not to Do? PLENARY ROOM

PA-3: Social Networks PA-4: Clinical Management 16:30-17:30 h Chairs: Nicholas Paton & Dan Wu 16:30-17:30 h Chairs: Chung Yan Grace Lui & Mark Boyd PLENARY ROOM BREAKOUT ROOM 16:30 h Using Social Networks in HIV Research 16:30 h HIV Treatment Outcomes Among People Weiming Tang, PhD, MD, MS Who Inject Drugs in the Asia-Pacific: an University of North Carolina Project-China, Observational Cohort Study (#O_07) China Win Min Han 16:50 h Network Analysis of the Sexual Relationship 16:40 h Prevalence Trend of Transmitted Drug and HIV Transmission in MSM – Studies in Resistance in a Prospective Cohort of Thai Hong Kong People with Acute HIV Infection (#O_08) Shui-Shan Lee, MD, FRCP, FRCPA, FFPH Camilla Muccini Stanley Ho Centre for Emerging Infectious 16:50 h Prevalence and The Impact of Low-level Diseases, Hong Kong Viremia Among People Living With HIV Taking Protease Inhibitors or Dolutegravir- 17:10 h Discussion based Antiretroviral Therapy (#O_09) Guan-Jhou Chen 17:00 h High Retention But Low Virological Suppression Rates Among HIV-infected Infants With Early Antiretroviral Treatment in the Thai National Program (#O_10) Thanyawee Puthanakit 17:10 h Lower Prevalence of TB Infection Before Initiating Antiretroviral Therapy After Treatment at Any CD4 in the Thai HIV National AIDS Program (#O_06) Watsamon Jantarabenjakul 17:20 h Discussion

17:30 h Break

10 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Program

Friday, 16 October Bangkok time

PL-2 Opportunistic Infections: TB/Fungal 18:00-19:15 h Chairs: Shinichi Oka & Jeremy Ross PLENARY ROOM 18:00 h TB Therapeutic Strategies Nicholas Paton, MD, FRCP National University of Singapore, Singapore

18:20 h HIV and STI: Addressing Infectious Syndemics in the Current Era Kenneth Mayer, MD Fenway Health, Harvard Medical School and Harvard TH Chan School of Public Health, USA

18:40 h Towards a Diagnostic-driven Approach to Prevention of HIV-associated Invasive Mycoses in SE Asia Thuy Le, MD, DPhil Duke University, USA, Oxford University Clinical Research Unit, Vietnam 19:00 h Discussion 19:15 h Break

PA-5: Clinical ART Management PA-6: High Burden of STIs 19:30-20:30 h Chairs: Thuy Le & Evy Yunihastuti 19:30-20:30 h Chairs: Reena Rajasuriar & Man-Po Lee PLENARY ROOM BREAKOUT ROOM 19:30 h Current Issues in Antiretroviral Therapy in 19:30 h Comparison of Digital and Facility-based HIV/ Pregnancy Syphilis Self-testing Secondary Distribution Thanyawee Puthanakit, MD Modes Among Men Who Have Sex With Men Chulalongkorn University, Thailand in China (#O_11) Yongjie Sha 19:40 h ART and Pregnancy: a Case-based Discussion Tavitiya Sudjaritruk, MD, ScM, PhD 19:40 h Modified Self-obtained Pooled Sampling Chiang Mai University, Thailand to Screen for Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection in Men Who 19:50 h Discussion Have Sex With Men (#O_12) 20:00 h Weight Gain and Antiretroviral Therapy: What’s Naokatsu Ando Going On, and What Should We Do? 19:50 h HCV Surges Among Thai MSM With HIV, Paul Sax, MD Fueled by Crystal Methamphetamine and Brigham and Women’s Hospital, Harvard Group Sex (#O_13) Medical School, USA Aswathy Varma 20:20 h Discussion 20:00 h Associated Factors With Sexually Transmitted Hepatitis C Virus Infection Among HIV- positive Men Who Have Sex With Men in Taiwan (#O_14) Yi-Ting Chen 20:10 h Cost-Saving of Pooled HCV RNA Testing to Diagnose Acute HCV Infection in High-Risk Populations (#O_15) Hsin-Yun Sun 20:20 h Discussion

20:30 h Break

20:45-21:45 h Capacity-building Session 4: Grant Workshop 101 Joseph Tucker, Wipaporn Natalie Songtaweesin, Benjamin Young and Phillip Chan PLENARY ROOM

21:45 h End of Day 2

11 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Program

Saturday, 17 October Bangkok time

PT-3: PrEP PT-4: Co-morbidities and Complications Among People Living with HIV 13:00-13:30 h Moderator: Fan Yang 13:00-13:30 h Moderator: Tavitiya Sudjaritruk PLENARY ROOM BREAKOUT ROOM Poster #: P_64, P_66, P_87, P_91 Poster #: P_14, P_15, P_16

13:30 h Break

PL-3: Viral Hepatitis 14:00-14:55 h Chairs: Hsi-Hsun Lin & Owen Tak-Yin Tsang PLENARY ROOM

14:00 h Hepatitis C Treatment in Thailand: Spotlight on C-Free Study. Community-based Testing & Treatment for People Who Use Drugs Tanyaporn Wansom, MD, PhD, MPP Dreamlopments, Thailand

14:20 h The Elimination of Hepatitis C in Australia - the Importance of Engaging With Prisoners Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD Burnet Institute, Australia 14:40 h Discussion 14:55 h Break

PL-4: Cure Research 15:05-16:00 h Chairs: Annette Sohn & Eugene Kroon PLENARY ROOM 15:05 h Functional Cure of HIV-1 Infection by PD1-vaccine-based Immunotherapy Zhiwei Chen, PhD, DVM AIDS Institute of University of Hong Kong, Hong Kong 15:25h Gene Silencing Strategies: si/shRNA for HIV Control Anthony Kelleher, MBBS, PhD, FRACP, FRCPA The Kirby Institute, Australia 15:45 h Discussion 16:00 h Break

12 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Program

Saturday, 17 October Bangkok time

PL-5: PrEP Implementation: Learning from PrEP Experts 16:10-18:00 h Chair: Nittaya Phanuphak PLENARY ROOM Session Introduction 16:10 h Nittaya Phanuphak, MD, PhD Institute of HIV Research and Innovation, Thailand Overview of PrEP in the Asia-Pacific 16:20 h Heather-Marie Schmidt, BMedSc(Hon), MPH, PhD UNAIDS/WHO, Thailand PrEP for KP Youth 16:40 h Wipaporn Natalie Songtaweesin, MBBS, DTMH Chulalongkorn University, Thailand PrEP, Chemsex and STIs 17:00 h Stephane Wen-Wei Ku, MD Taipei City Hospital, Renai Branch, Taiwan Natthakhet Yaemim, MD 17:10 h Pulse Clinic, Thailand Universal Coverage of PrEP in Thailand 17:20 h Taweesap Siraprapasiri Ministry of Public Health, Thailand 17:40 h Q&A with the Audiences Closure of the Conference 18:00 h Nittaya Phanuphak, Mark Boyd, Patrick Li

VIDEO-ON-DEMAND

ASHM symposium (56’) IAS symposium (68’) Youth Against AIDS symposium (28’)

Candid Conversations from the Translating Research Evidence into Moving Sexuality Education Online. Frontline – Supporting the HIV & Sexual Action: CIPHER Grant Programme in Opportunities, Challenges and Health Workforce Throughout the the Asia-Pacific Region Experiences: a Panel Discussion COVID-19 Pandemic

13 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Program

Capacity-building sessions

APACC is offering 4 capacity-building sessions this year. The aim of these interactive sessions is to strengthen our participant’s skills in research methodology and to discuss how to prepare their submission for international journals. Each session is faciliated and moderated by experts in the field and the sessions are designed to be interactive and engaging.

Creating “Super” Models: a Biostatistics Workshop Thursday 15 October, 18:00-19:00h Bangkok time (UTC+7)

The session is prepared for an early-career researcher audience, focusing on biostatistics analytical decisions made after you have a clean cross-sectional data set. It will cover the fundamental concepts and common practices of regression model selection and results interpretation. Stephen Kerr Sirinya Teeraananchai Fan Yang HIVNAT, Chulalongkorn HIVNAT, Kasetsart UNC at Chapel Hill - University University Project China

JIAS Scientific Writing Workshop: How to Write and Submit a Research Manuscript Thursday 15 October, 19:15-20:15h Bangkok time (UTC+7)

Publishing scientific papers is an essential part of a researcher’s career. This interactive workshop aims to build skills in scientific writing, helps to understand the editorial process, and provides useful and practical information to support new- and early-career HIV researchers, as well as more experienced Kenneth Mayer Tavitiya Sudjaritruk researchers, in successfully submitting their manuscripts to peer-reviewed Harvard Medical School Chiang Mai University and Harvard TH Chan journals. School of Public Health

Love at First Sight: Crafting Appealing Infographics Thursday 15 October, 20:30-21:30h Bangkok time (UTC+7)

Do your research manuscript figures jump off the page or stumble back into the text? This session will provide practical advice on designing infographics and related content for research manuscripts. An infographic is an image that Joseph Tucker Krittaporn Termvanich presents information for a non-expert audience. UNC at Chapel Hill Institute of HIV Research and Innovation

Grant workshop 101 Friday 16 October, 20:45-21:45h Bangkok time (UTC+7)

Apart from brilliant research ideas, understanding funder priorities and reviewer considerations are essential for successful research funding applications. Benjamin Young (ViiV Healthcare), Joseph Tucker (UNC at Chapel Hill), and Wipaporn Natalie Benjamin Young Joseph Tucker Wipaporn Natalie Phillip Yin Cheung Chan Songtaweesin (Chulalongkorn University) ViiV Healthcare UNC at Chapel Hill Songtaweesin Hong Kong University of Chulalongkorn Science and Technology, will share their respective views as funder, Universityina Institute of HIV Research reviewer and applicant of research grants. and Innovation

14 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Program

Symposiums

Putting the Person Back into Person-Centered Care and Treatment Thursday 15 October, 15:30-16:30h Bangkok time (UTC+7)

A central tenet of medicine is that people living with the HIV (PLHIV) should be involved in the decision-making that affects their lives. In this symposium, you will hear from experts on why and how the experiences of PLHIV can inform care delivery and identify needs of drug discovery; learn how current and future antiretroviral therapies can address these needs.

HIV Management During COVID-19: What to Do & What Not to Do? Friday 16 October, 15:30-16:30h Bangkok time (UTC+7)

COVID-19 has infected more than 33 million people worldwide (as of 28 Sept 2020) and continues to be a significant threat to all of us. Across Asia, although the impact of COVID-19 varies considerably, interactions between healthcare providers and people living with HIV or at risk of HIV are being compromised due to the response and reaction to this pandemic. Join our session with Dr Nittaya Phanuphak, Prof Chien-Ching Hung and Dr Chen Seong Wong to learn from their experiences on adapting HIV services and management for the pandemic in Thailand, Taiwan and Singapore.

Translating Research Evidence into Action: CIPHER Grant Programme in the Asia Pacific Region Video-on-demand

Through its Grant Programme, the IAS Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) provides seed funding to early-stage investigators to address critical research gaps, while providing a unique opportunity for professional development. A key aim of the programme is to build research capacity within resource-limited settings by fostering the next generation of investigators in paediatric and adolescent HIV. CIPHER is hosting this evidence to action forum with the ambition to increase implementers’ and country level policy makers’ engagement in ongoing research as well as to faster translation of evidence into tangible actions. This symposium will be an opportunity to meet CIPHER Grantees based in the Asia Pacific region and learn more on their research while also discussing the barriers and challenges faced by early-stage investigators to receive research grants and develop professionally.

15 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Program

Candid Conversations from the Frontline – Supporting the HIV & Sexual Health Workforce Throughout the COVID-19 Pandemic Video-on-demand

A series of candid conversations from across the region on the impact of the COVID-19 pandemic on the frontline workforce in our sector. To help respond to their unique needs of the HIV, BBV and SRH workforce during this turbulent time, ASHM initiated a COVID-19 Taskforce and Regional Advisory Group to provide support and advice. Join us as we discuss what went well in the rapid adaptation of services, what mistakes we can learn from, the innovations healthcare workers hope to continue into the new normal and the importance of protecting the mental health of healthcare workers through uncertainty.

Moving Sexuality Education Online. Opportunities, Challenges and Experiences: a Panel Discussion Video-on-demand

On this panel, Youth Against AIDS engages young leaders in the field of SHRH in a conversation about online sexuality education. Young people are increasingly shifting online to gather information on sexual health. While this development can enable new ways of information provision for youth, new hurdles arise. Our panelists discuss various challenges, share their experiences, and envision a future where sex education can take place in a safe space online in which no one is afraid to ask questions.

16 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Faculty

17 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Faculty

FELLOW SCIENTIFIC COMMITTEE Phillip Yin Cheung Chan Zhiwei Chen MBChB, MRCP (UK), FHKCP, PhD, DVM FHKAM AIDS Institute of University Hong Kong University of Science of Hong Kong, Hong Kong and Technology, Hong Kong; Institute of HIV Research and Innovation, Thailand

Phillip Chan is a neurologist by training. After graduation Zhiwei Chen is the founding director of the AIDS from the medical school of the Chinese University of Institute, which was established in 2007, at The Hong Kong, he completed his fellowships in internal University of Hong Kong, Li Ka Shing Faculty of medicine and Neurology at the Queen Elizabeth Hospital Medicine. In 1996, Dr. Chen graduated from the Aaron of Hong Kong. In 2015, he joined the Institute of HIV Diamond AIDS Research Center (ADARC) and obtained Research and Innovation in Thailand and has been his Ph.D. degree in New York University School of working for NeuroHIV projects in affiliated with US Medicine, USA. From 1996 to 2007, he progressed Military HIV Research Program, UCSF and Yale University. from a post-doc to a research scientist, and then to a Apart from his interest in neuroinfectious diseases, he staff investigator/assistant professor all at ADARC of also works with the Hong Kong University of Science and the Rockefeller University. He has been engaged in Technology for Alzheimer’s disease research projects studies of HIV origin, molecular mechanisms of HIV/SIV since 2018. entry, and AIDS vaccine since 1991. He was the first to isolate simian AIDS virus from wild Sooty Mangabeys in West Africa, to identify a new subtype F of HIV-2, and to Potential conflict of interest: demonstrate monkey CCR5 as a key second receptor for No conflict of interest to report HIV and SIV. Currently, he focuses his research areas on AIDS preventive drugs and vaccines with recent peer- reviewed articles published in JV, JBC, JCI, etc. He was an inventor/co-inventor of two AIDS vaccines recently finished clinical phase one trails in the US.

He has published over a hundred SCI papers and received numerous research grants as a PI from NIHR32, amFAR, NIHR01, Gates Foundation in US; RGC, RFCID and ITF in Hong Kong, as well as a project leader of 973, 11th- and 12th- Mega grants in mainland China. He also serves as an academic editor for PLoSONE, and an editorial board member for JAIDS, JMP and JNIP.

Potential conflict of interest: No conflict of interest to report

18 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Faculty

INVITED SPEAKER INVITED SPEAKER Bum Sik Chin Tanat Chinbunchorn MD, PhD MD National Medical Center, Institute of HIV Research and South Korea Innovation, Thailand

Bum Sik Chin graduated Yonsei University College of Tanat Chinbunchorn is the technical lead and research Medicine in 1999 in South Korea and received M.D. physician at the Institute of HIV Research and Innovation PhD. at the same university in 2010. He is working as Bangkok, Thailand. His research is mainly focused on an ID doctor at Center for Infectious Diseases, National implementation science through key populations led Medical Center in Seoul, South Korea since 2010 and health services (KPLHS) in HIV treatment and prevention, he is head of Infection Control Office of the institution. transgender health, scaling up of HIV services, and its He had been at AIDS Research Institute, University regionalization in the Asia Pacific. of California, San Diego as a visiting scholar for one year in 2014. His research interest is HIV patient care Tanat currently leads the “Princess PrEP” project which and emerging infectious diseases preparedness and is Thailand’s first and largest PrEP program by trained education of healthcare workers against emerging KP-lay providers. He also manages the first same-day infectious diseases. initiation of antiretroviral service in the country at the Thai Red Cross Anonymous Clinic and differentiated service delivery for ART among provinces with a high Potential conflict of interest: HIV burden in Thailand. He provides high-quality No conflict of interest to report technical assistance in facilitating private-public partnership models for HIV services to serve Bangkok as a fast track city to ending AIDS. He graduated from a joint medical program between the University of Nottingham, UK, and Srinakharinwirot University, Thailand with first-class honors.

Potential conflict of interest: No conflict of interest to report

19 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Faculty

INVITED SPEAKER INVITED SPEAKER Margaret Hellard Rena Janamnuaysook AM, MBBS, FRACP, FAFPHM, MBA PhD Institute of HIV Research and Burnet Institute, Australia Innovation, Thailand

Margaret Hellard AM is a Deputy Director at the Burnet Rena Janamnuaysook is a transgender woman and a Institute, Head of Hepatitis Services in the Infectious human rights advocate from Bangkok, Thailand. She Diseases Unit at The Alfred Hospital and an Adjunct works as a program manager for transgender health at Professor of Infectious Diseases Epidemiology at Monash the Institute of HIV Research and Innovation, where she University and University of Melbourne in Melbourne, established the Tangerine Community Health Clinic, the Australia. first transgender-led sexual health and well-being clinic for transgender people in the region. Margaret’s principal research interests are in preventing the transmission and improving the management of Rena also leads the Tangerine Academy for Transgender blood borne viruses, with the ultimate aim to eliminate Health, where she provides technical assistance and hepatitis C and hepatitis B as a public health threat and capacity building interventions on transgender health, end the AIDS epidemic. key population-led health services, social innovations, including HIV counseling and testing, pre-exposure Margaret is a member of numerous advisory committees prophylaxis, same-day antiretroviral treatment and and working groups on viral hepatitis and HIV within implementation research to government partners, Australia and globally, including Co-Chairing the WHO community-based organizations and private sectors. Strategic and Technical Advisory Group on HIV and She co-founded the Thai Transgender Alliance, the Viral Hepatitis and Chairing the World Innovation Health first transgender-owned human rights organization in Summit Viral Hepatitis Forum (2018). She has over 400 Thailand. She received a master degree in international peer reviewed publications and $70 million in research development from the University of Birmingham, United grants and tenders. Kingdom.

Potential conflict of interest: Potential conflict of interest: Gilead Sciences, Abbvie, BMS Gilead Sciences

20 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Faculty

INVITED SPEAKER INVITED SPEAKER Adeeba Kamarulzaman Anthony Kelleher MBBS, FRACP, FAMM, FASc, MBBS, PhD, FRACP, FRCPA HonLLD Monash, DPMP The Kirby Institute, Australia University of Malaya, Malaysia

Adeeba Kamarulzaman is presently the Dean of the Anthony (Tony) Kelleher is a clinician scientist. He Faculty of Medicine, University of Malaya. In 2007 she graduated from Medicine at UNSW in 1986. He trained in established the Centre of Excellence for Research in internal medicine and pathology at St Vincent’s Hospital, AIDS (CERiA) at the University of Malaya to develop Sydney at the height of the HIV epidemic, qualifying as a and enhance HIV related research activities in Clinical Immunologist and Immunopathologist in 1995. Malaysia. CERiA’s research efforts focus on key affected populations and transcend clinical, translational as well Professor Kelleher completed his PhD in 1997, describing as public health research. Professor Kamarulzaman has the modulation of the HIV infected immune system by used her clinical and academic leadership to engage a range of interventions including therapeutic vaccines in evidence-based response to the HIV epidemic in and IL-2. He made the first observations describing the Malaysia and the region. She is presently the President- reconstitution of antigen specific CD4+ T cell responses Elect of the International AIDS Society and was recently in patients receiving potent anti-retroviral therapy in honoured with a Doctor of Laws honoris causa from her the context of an early phase trial of the HIV protease alma mater, Monash University. inhibitor, Ritonavir.

Professor Kelleher was appointed Director of the Kirby Potential conflict of interest: Institute at UNSW Sydney in early 2019. He is also Head No conflict of interest to report of the Kirby Institute’s Immunovirology and Pathogenesis Program, and Principal of the Infection Immunology and Inflammation Theme at UNSW Medicine. As a clinical academic at St Vincent’s Hospital Sydney, Professor Kelleher is responsible for clinical care of patients with HIV infection and autoimmune diseases as well as oversight of the NSW State HIV Reference laboratory.

Potential conflict of interest: CSL

21 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Faculty

INVITED SPEAKER INVITED SPEAKER Stephen Kerr, Aamir Khan, BPharm(Hons), MIPH, PhD MD, PhD HIV-NAT, Chulalongkorn IRD, Singapore University, Thailand

Aamir Khan is a medical epidemiologist and social Stephen Kerr is a pharmacist who trained in biostatistics. entrepreneur based in Singapore. He is currently Professor and Director of the Biostatistics Excellence Centre at Chulalongkorn University, and In 2004, Dr. Khan co-founded Interactive Research and Head of Biostatistics at HIV-NAT, The Thai Red Cross Development (IRD), a Singapore-based not-for-profit AIDS Research Centre in Bangkok, Thailand. He has an committed to improving global health and development honorary appointment at the Kirby Institute, University through process and technology innovations. IRD has of New South Wales, Australia. His research interests are global health delivery teams operating from offices in pharmacokinetics of antiretroviral and anti-TB agents, in Dhaka, Dubai, Ho Chi Minh, Jakarta, Johannesburg, neurodevelopment in adolescents and latent class Karachi and Lagos supporting programs in over 20 models. countries. He has led large scale service delivery grants from Global Fund for diagnosing, treating and preventing TB, HIV and Malaria. His research currently Potential conflict of interest: focuses on lung health and immunizations, and No conflict of interest to report sustainable models of free and low-cost health care.

Dr. Khan is Founder and CEO of Alcela, a healthcare delivery and technology accelerator based in Singapore. Alcela supports early-stage health-technology and healthcare delivery companies to grow and scale through mentorship, access to markets and investments.

Dr. Khan is also co-founder and director of two social businesses that have received over USD 20m of funding. Interactive Health Solutions, based in Singapore, utilizes information technologies and diagnostic market innovations to improve access to health care. Community Health Solutions, based in Karachi, is an aggregator of affordable lung health and chronic disease care in the private sector.

Dr. Khan trained in medicine at the Aga Khan University and has a PhD in international health from the Johns Hopkins University.

Potential conflict of interest: No conflict of interest to report

22 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Faculty

INVITED SPEAKER ORGANIZING COMMITTEE Stephane Wen-Wei Ku Thuy Le MD MD, DPhil Taipei City Hospital, Renai Duke University, USA; Branch, Taiwan Oxford University Clinical Research Unit, Vietnam

Stephane Wen-Wei Ku completed his medical degree at Thuy Le is an Associate Professor of Medicine at National Taiwan University in 2008. He had his Internal Duke University, an Adjunct Associate Professor of Medicine and Infectious Diseases specialist training at Medicine at the University of Hawaii and a Visiting Taipei Veterans General Hospital in 2013. He is currently Fellow at the Oxford University Clinical Research Unit working as director of Division of Infectious Diseases at in Vietnam. She leads a research program to improve Taipei City Hospital Renai Branch and clinical researcher HIV clinical outcomes in Southeast Asia by mitigating with TREAT Asia Network at Taipei Veterans General HIV drug resistance development and developing novel Hospital. Dr. Ku’s research interests include HIV/AIDS, diagnostics and treatment strategies for a leading sexually-transmitted diseases, Chemsex, and sexual HIV-associated opportunistic infection caused by the wellbeing of LGBT community and has been actively dimorphic fungus Talaromyces marneffei. She led involved in PrEP implementation in Taiwan. Dr. Ku is a the IVAP clinical trial in talaromycosis treatment that member of the Taiwan Infectious Diseases Society and demonstrated the superiority of amphotericin B over currently a Council Member of Taiwan AIDS Society. itraconazole in reducing deaths. The study has redefined international treatment recommendations for this important endemic mycosis and calls for amphotericin Potential conflict of interest: to be made widely available in Asia. No conflict of interest to report She is a Member of the Program Committee for the Asia Pacific AIDS and Co-Infection Conference, Member of several WHO Guidelines Committees on Management of HIV, Member of the NIH/CDC/HIVMA/ IDSA Guidelines Committee on Opportunistic Infections, and a Coordinator of the European Confederation of Medical Mycology Guidelines for Endemic Mycoses. She has published in the New England Journal of Medicine, Lancet, Clinical Infectious Diseases, AIDS, and Antiviral Therapy.

Potential conflict of interest: Gilead Sciences

23 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Faculty

INVITED SPEAKER SCIENTIFIC COMMITTEE Shui-Shan Lee Linghua Li MD, FRCP, FRCPA, FFPH MD, PhD The Chinese University of Hong Guangzhou Eighth People’s Kong, Hong Kong Hospital, China

Shui-Shan Lee is a clinician and specialist in internal Linghua Li is the Vice-Director of the Centre for medicine, immunopathology and public health. Infectious Diseases of Guangzhou Eighth People’s He is currently Daniel Yu Research Professor of Hospital. She is a specialist in charge of the AIDS Infectious Diseases of The Chinese University of Hong Clinical Service at Guangzhou Eighth People’s Hospital Kong. Between 1991 and 2005, Dr Lee headed the from 2007 till now. she is also in charge of the training Government’s AIDS program, during which he directed of interns and residents about infectious diseases. Hong Kong’s HIV prevention, control and treatment Her research interest is in AIDS-related opportunistic services. He is now Deputy Director of The Chinese infections and antiretroviral therapy of HIV. University’s Stanley Ho Centre for Emerging Infectious Diseases. He has, on different occasion, served as Dr. Li is currently Vice Chairman of Youth Committee consultant to national and international organizations in for China Sexually Transmitted Diseases and AIDS the assessment of HIV situations, program evaluations, Association, and Vice Deputy director of Youth and harm reduction development. His major areas of Committee for Infectious Diseases Branch of research interest include optimization of HIV treatment, Guangdong Medical Association infectious disease epidemiology, spatio-temporal Dr. Li graduated from the Faculty of Medicine of Peking dimensions of transmission of infections. He has University Medical School in 1997 and received Ph.D authored over 200 peer-reviewed articles, about 40 on Infectious Diseases of The Third Affiliated Hospital, book chapters, and is the editor of the HIV Manual in Sun Yat-sen University. She was a visiting scholar at Hong Kong. Infectious Diseases Department of Duke University and University of North Caronia in USA from 2011 to 2013.

Potential conflict of interest: Dr Li has co-authored over 50 papers in local and Gilead Sciences international peer-reviewed journals and held nearly one million funding from national and local grants.

Potential conflict of interest: No conflict of interest to report

24 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Faculty

INVITED SPEAKER INVITED SPEAKER Jingjing Li Yi-Chun Lo MA MD Social Entrepreneurship to Spur Taiwan CDC, Taiwan Health (SESH), China

Jingjing Li is a research assistant at the Social Yi-Chun (Philip) Lo is currently Deputy Director-General Entrepreneurship to Spur Health (SESH), a group and spokesperson of Taiwan CDC and adjunct infectious focused on using crowdsourcing to improve health. disease physician at National Taiwan University Hospital. Her current research project focuses on using Since changing career path from clinical medicine to crowdsourcing to promote hepatitis C testing uptake in public health in 2008, Dr. Lo has been dedicated to Shenzhen, China. With a background in experimental controlling the HIV epidemic and associated coinfection and social psychology, she is particularly interested outbreaks among MSM (e.g., HCV, shigellosis, hepatitis in understanding the sociocultural factors underlying A) as well as responding to emerging threats including public health challenges and leveraging social H7N9, ebola, MERS, zika, chikungunya and most recently innovation approach to implement evidence-based COVID-19 in Taiwan. He is also a leading advocate in the health programs. Jingjing received her BA in psychology Taiwanese government for HIV self-testing, PrEP, and from Duke University and MA from New York University. legal protection policies among key populations.

Potential conflict of interest: Potential conflict of interest: No conflict of interest to report. No conflict of interest to report

25 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Faculty

INVITED SPEAKER ORGANIZING COMMITTEe Kenneth Mayer Nicholas Paton MD MD, FRCP Fenway Health, Harvard Medical National University of Singapore, School and Harvard TH Chan Singapore School of Public Health, USA

Kenneth Mayer trained in Internal Medicine at Beth Nicholas Paton trained in medicine and infectious Israel Hospital and in Infectious Diseases and Molecular diseases in Cambridge, Sydney and London, and in Epidemiology at Brigham and Women’s Hospital. As the epidemiology at the London School of Hygiene and founding Medical Research Director of Fenway Health, Tropical Medicine. From 1997 to 2005 he worked he created a community health research program as Head of the Infectious Diseases Department and that has developed an international reputation for its Hospital Research Director at Tan Tock Seng Hospital, capability to conduct community-based research. He Singapore. He then returned to the UK to take up a is currently a Professor of Medicine at Harvard Medical position at the Medical Research Council Clinical Trials School, a Professor in Global Health and Population Unit, leading large-scale HIV treatment trials such as at the Harvard TH Chan School of Public Health, and PIVOT (the largest UK-only HIV treatment trial, enrolling Attending Physician and Director of HIV Prevention >560 patients at 45 sites) and EARNEST (the definitive Research at Beth Israel Deaconess Hospital. Starting in trial of second-line HIV treatment for the World Health 1994, he has been a site Principal Investigator of NIH- Organization’s public health approach, enrolling >1200 funded HTVN, HPTN, MTN, and ATN clinical trials units, patients at 14 sites in 5 sub-Saharan African countries). focusing on bio-behavioral HIV prevention research, He was also involved in two international HIV trials and a member of the scientific leadership of HPTN and networks – INSIGHT (NIH-funded) and NEAT (EU-funded). HVTN. Prof. Paton returned to Singapore in 2011 as Professor He has co-authored more than 800 peer-reviewed in the Department of Medicine, National University of publications, co-authored the first text on AIDS for the Singapore, where he has focused on tuberculosis (TB), general public and has co-edited 5 academic texts. He in particular clinical trials of new treatments for TB and has served on the national boards of amfAR, HIVMA, novel approaches to test new drugs and combinations. and GLMA, was a member of the CDC/HRSA HIV/ He has established a number of bilateral collaborations AIDS Advisory Committee, and was a member of the with TB research centres in Asia to evaluate new TB Governing Council of the International AIDS Society. He drugs using novel experimental approaches. He leads is an Editor-in-Chief of the Journal of the International a clinical trial of anti-IL-4 immune-based therapy for AIDS Society, and serves on the PEPFAR Scientific TB and is the Chief Investigator on a new trial for Advisory Board. drug-sensitive TB to be conducted in multiple sites in Asia (TRUNCATE-TB). He also leads a comprehensive programme spanning basic science to public health Potential conflict of interest: to find better approaches for TB: The Singapore Gilead Sciences, Merck Programme of Research Investigating New Treatments for TB (SPRINT-TB), which is supported by the National Medical Research Council in Singapore.

Potential conflict of interest: Janssen, GSK

26 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Faculty

ORGANIZING COMMITTEE INVITED SPEAKER Nittaya Phanuphak Thanyawee Puthanakit MD, PhD MD Institute of HIV Research and Chulalongkorn University, Innovation, Thailand Thailand

Nittaya Phanuphak is currently the Executive Director at Thanyawee Puthanakit is a pediatric infectious disease the Institute of HIV Research and Innovation in Bangkok, specialist at Department of Pediatrics, Faculty of Thailand. She has deep interest in HIV prevention and Medicine, Chulalongkorn University, Bangkok, Thailand. key populations (KP), especially around the use of Key She is a former trainee of the Johns Hopkins University Population-Led Health Service (KPLHS) approaches Fogarty AIDS International Training and Research to enhance access to HIV testing, prevention and Program. She started her clinical research in pediatric treatment among men who have sex with men and HIV/AIDs focusing on opportunistic infections and transgender women. She currently works actively with antiretroviral therapy in resource limited settings at community and government partners to establish a Research Institute of Health Sciences, Chiang Mai national technical assistance platform to support the University in 2002. She is a leader in pediatric HIV accreditation and legalization of KP lay providers to treatment and care in Asia. She leads several multicenter ensure KPLHS sustainability through domestic financing research projects in Thailand, Cambodia, Indonesia and mechanism. also collaborates with TREAT Asia research program.

In 2015, she supported the establishment of the She has served on the writing committee for the Tangerine Community Health Center at TRCARC using WHO’s pediatric HIV treatment guideline and Thai integrated hormone therapy and sexual health service National Guideline. Her research interest in pediatric approach to effectively bring almost 3,000 transgender and adolescent HIV include antiretroviral therapy and women (TGW) and transgender men into services over elimination of perinatal HIV transmission and reduction a 3-year period. The model is currently being expanded in new cases of adolescent infection. She conducted to community-based organizations (CBOs), as well as a pilot national program using integrase inhibitors public and private clinics, working with transgender intensification regimen for late-presenting pregnant people in the region. women.

Potential conflict of interest: Potential conflict of interest: No conflict of interest to report ViiV, MSD

27 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Faculty

INVITED SPEAKER INVITED SPEAKER Paul Sax Heather-Marie Schmidt MD BMedSc (Hon), MPH, PhD Brigham and Women’s Hospital UNAIDS Asia Pacific Regional (BWH), Harvard Medical School, Support Team and the World USA Health Organisation, Thailand

Paul E. Sax is Clinical Director of the Division of Heather-Marie Schmidt has a background in medical Infectious Diseases and the HIV Program at Brigham and microbiology, research, evaluation and public health Women’s Hospital (BWH), and Professor of Medicine at policy with experience across a range of population Harvard Medical School. Dr. Sax received his MD from and public health priority areas including HIV, STIs and Harvard Medical School, did his residency in Internal viral hepatitis, infection control and multi-resistant Medicine at BWH, then fellowship in Infectious Diseases organisms, and non-communicable diseases. As a at Massachusetts General Hospital. He is Editor-in-Chief Senior Policy Analyst for the New South Wales Ministry of Open Forum Infectious Diseases, is Section Editor of of Health in Australia, she played a leading role in HIV/AIDS in UpToDate, on the Editorial Board of NEJM the EPIC-NSW trial, which recruited almost 10,000 Journal Watch Infectious Diseases (where he writes participants between March 2015 and March 2018. the HIV and ID Observations blog), and on the editorial She worked with the regional NGO APCOM on PULSE: advisory board of Medscape HIV/AIDS. Dr. Sax is also on a research, advocacy and capacity building project to the core faculty of the International AIDS Society – USA, improve the HIV response for young MSM in the Greater and teaches regularly on HIV and infectious diseases Mekong. She became the regional advisor for HIV pre- locally, nationally, and internationally. In addition to his exposure prophylaxis (PrEP), a position jointly funded by clinical practice and teaching, Dr. Sax’s ongoing areas of the World Health Organization and the UNAIDS Regional research include clinical trials of antiretroviral therapies, Office for Asia and the Pacific, in September 2018. She is cost-effectiveness of management strategies for HIV, passionate about improving the public health response and toxicity of antiretroviral therapy. He is presently to help end HIV transmission across the Asia-Pacific the principal investigator at the BWH AIDS Clinical region, particularly with the introduction of PrEP as an Trials Unit, and is a member of the Cost-Effectiveness additional HIV prevention option. of Preventing AIDS Complications (CEPAC) Research Group. Potential conflict of interest: No conflict of interest to report Potential conflict of interest: Gilead Sciences, GSK/ViiV, Merck, Janssen, UpToDate, Medscape, NEJM Journal Watch, Open Forum Infectious Diseases

28 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Faculty

INVITED SPEAKER INVITED SPEAKER Taweesap Siraprapasiri Wipaporn Natalie MD, MPH Songtaweesin Ministry of Public Health, Royal MBBS, DTMH Thai Government, Thailand Chulalongkorn University, Thailand

Taweesap Siraprapasiri is a senior medical officer at Wipaporn Natalie Songtaweesin is a paediatrician Thailand’s Disease Control Department of the Ministry of and clinical researcher at Chulalongkorn University in Public Health. He had served in several key positions in Bangkok, Thailand. She is a CIPHER Grantee, NIH R21 the national HIV program and as advisors at international recipient and NIH D43 fellow and conducts clinical trials level including UNFPA, UNAIDS, WHO, and the Global in HIV prevention using mobile health technologies Fund. Dr. Taweesap is a key member of the task team and integration of mental health screening and care who advocates and supports the development of PrEP for adolescent service delivery in Thailand. Her clinical program in Thailand from research, pilot, expands, and work involves treatment of pediatric and adolescent HIV includes PrEP service as the benefit package in universal and prevention of HIV in adolescents. In 2018 she was health coverage in Thailand. a member of the writing team of the Thai National PrEP Guidelines and in 2019 joined the WHO PrEP working group for adolescents and young adults. Potential conflict of interest: No conflict of interest to report Potential conflict of interest: No conflict of interest to report

29 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Faculty

FELLOW INVITED SPEAKER Tavitiya Sudjaritruk Weiming Tang MD, ScM, PhD PhD, MD, MS Chiang Mai University, Thailand University of North Carolina at Chapel Hill - Project China, China

Tavitiya Sudjaritruk is a pediatric infectious disease Weiming Tang is an assistant professor of University specialist at the Department of Pediatrics, Faculty of of North Carolina at Chapel Hill, and the assistant Medicine, Chiang Mai University, Chiang Mai, Thailand. director of University of North Carolina Project-China. After the Pediatric Infectious Diseases Fellowship His research is mainly focused on developing different Training Program, she was awarded the Ananda Mahidol intervention to promote HIV testing among key Scholarship under the Royal Patronage of His Majesty populations. the King of Thailand to pursue the graduate study aboard at the Johns Hopkins Bloomberg School of Dr. Tang graduated from the Fielding School of Public Public Health, Johns Hopkins University, United States Health of the University of California, Los Angeles in of America. She completed her master and doctoral 2014, and received training in Epidemiology. degrees in Infectious Disease Epidemiology from the Department of Epidemiology, Johns Hopkins Bloomberg Dr. Tang has co-authored over 100 papers in local and School of Public Health in 2013 and 2016, respectively. international peer-reviewed journals.

As a physician-researcher with broad-based training in pediatrics, infectious diseases, epidemiology and public Potential conflict of interest: health, she focuses her research areas of interest on No conflict of interest to report HIV/AIDS among pediatrics and adolescents living in resource-limited countries. She leads several multicenter clinical research studies, including long-term, non- infectious complications, opportunistic infections, vaccination and re-vaccination against important vaccine preventable diseases among these populations. She has also been the recipient of numerous awards and honors in this research field.

Potential conflict of interest: No conflict of interest to report

30 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Faculty

INVITED SPEAKER INVITED SPEAKER Junko Tanuma Sirinya Teeraananchai MD, PhD PhD National Center for Global Health HIV/NAT, Kasetsart University, and Medicine, Japan Department of Statistics, Faculty of Science, Thailand

Junko Tanuma is Chief of Division of the AIDS Medical Sirinya Teeraananchai is a biostatistician who graduated Information at AIDS Clinical Center in the National PhD in biostatistics from the Kirby Institute, University of Center for Global Health and Medicine. She graduated New South Wales, Australia. She is currently a lecturer at from Tohoku University Medical School and earned a Department of Statistics, Faculty of Science, Kasetsart PhD at the Graduate School of Tohoku University. She University, and a biostatistician at HIV-NAT, The Thai was a Research Fellow in the Takemi Program at Harvard Red Cross AIDS Research Centre in Bangkok, Thailand. T.H. Chan School of Public Health in 2014-2016. She has Her research interests are long-term outcomes of HIV- a broad background as an infectious disease physician, infected patients and using longitudinal model to assess with specific training and expertise in the field of HIV/ factors associated outcomes in adolescents and also AIDS. She is now serving as the PI of the Sexual Health youth who had a co-infection as HPV infection. Research Programs for the Tokyo Olympic Games in 2020 supported by the Japanese government, where she leads a team that plans and conducts the programs Potential conflict of interest: that will help the visitors and community take STD/HIV IAS tests and preventions during the Olympic seasons and is building a network across Tokyo metropolitan area for sexual health promotion with STD/HIV clinics and NGO/ NPOs.

Potential conflict of interest: No conflict of interest to report

31 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Faculty

INVITED SPEAKER ORGANIZING COMMITTEE Krittaporn Termvanich Joseph Tucker MA MD, PhD, AM Institute of HIV Research and University of North Carolina at Innovation, Thailand Chapel Hill, USA

Krittaporn Termvanich, M.A., has a background in digital Joseph D. Tucker is an infectious diseases physician with media (Queensland University of Technology, Brisbane, a special interest in using crowdsourcing to improve Australia), and is currently the Communications Manager health. He is UNC Assistant Professor of Medicine, at the Institute of HIV Research and Innovation, based Director of UNC Project-China, and Chairman of SESH in Bangkok, Thailand. She started her career in HIV Global. He leads US National Institutes of Health grants program management, and switched to communications totaling over seven million USD. His team’s ongoing to pursue her passion for knowledge translation and research investigates crowdsourcing to promote HIV data visualization, which she has been doing for over testing, the social science and ethics of curing HIV, five years. She now stands between the creative and the health of African migrants in Guangzhou, and trust scientific worlds, leading a creative team at the Institute in patient-physician relationships. His New England of HIV Research and Innovation in curating data as well Journal of Medicine article on the social roots of syphilis as research findings and translating these into attractive, in China helped catalyze policy change and spurred clear, uniform, and easy to understand messages for the development of a national 10 year plan to control the general public, HIV doctors and programmers, syphilis. He is the Chairman of the Steering Committee researchers and scientists, and others working in the of Social Entrepreneurship for Sexual Health (SESH), field. a group focused on using crowdsourcing to improve health. He helped to organize the HepTestContest soliciting innovative HBV and HCV testing models. He is Potential conflict of interest: a Term Member of the Council on Foreign Relations. He No conflict of interest to report has contributed to several World Health Organization guidelines. Joe received his BA from Swarthmore, MD from UNC, AM (RSEA) from Harvard, and PhD from the London School of Hygiene and Tropical Medicine.

Potential conflict of interest: No conflict of interest to report

32 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Faculty

INVITED SPEAKER INVITED SPEAKER Tanyaporn Wansom Natthakhet Yaemim MD, PhD, MPP MD Dreamlopments, Thailand Pulse Clinic, Thailand

Tanyaporn Wansom is currently Director of Research Natthakhet (Deyn) Yaemim founded PULSE, a pan-Asian and Advocacy at Dreamlopments and protocol chair sexual health network of medical clinics and services of the C-Free Study. She also volunteers as a study in Asia in 2015 when he was 28. Dr Deyn earned his physician at the Thai Red Cross AIDS Research Centre medical degree in Thailand and did advanced studies in and is an investigator on the Hepatitis Transformative Japan and Thailand. He is affiliated as a researcher with Science Committee of the AIDS Clinical Trial Group Maastricht University, Netherlands. (ACTG). Previously, she served as the Director for Clinical Research for the Department of Retrovirology at the Armed Forces Research Institute for Medical Sciences in Potential conflict of interest: Bangkok, Thailand. No conflict of interest to report

Dr. Wansom graduated with high honors with bachelor’s degrees in Chinese Studies and Biology from Swarthmore College, received her master’s in public policy and medical doctorate from the University of Michigan, and her PhD in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. She is American board-certified in internal medicine and infectious diseases, and completed her residency and fellowship training at Johns Hopkins University School of Medicine in Baltimore, Maryland.

Potential conflict of interest: No conflict of interest to report

33 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Faculty

FELLOW INVITED SPEAKER Fan Yang Benjamin Young PhD, MSc MD, PhD University of North Carolina at ViiV Healthcare, USA Chapel Hill - Project China, China

Fan Yang is a postdoctoral research fellow at University Benjamin Young is Head of Global Medical Directors of of North Carolina Project-China, based in Guangzhou, ViiV Healthcare where he supports clinical education, China, where she co-led a randomized controlled trial medical research and public health initiatives around as part of the Social Entrepreneurship to Spur Health the world. From 2012 to 2018, Dr. Young was Senior Vice (SESH) group and capacity building at Guangdong President and Chief Medical Officer of the International Province Dermatology Hospital STD control department. Association of Providers of AIDS Care, where he oversaw Fan completed her PhD at the Johns Hopkins University capacity-building programs and coordinated evidence- School of Public Health in 2018. She received her informed policies with the United Nations and the World master’s and bachelor’s degrees in Global Health Health Organization. and pharmaceutical sciences from Duke University and Peking University. Her research focuses on HIV With over 20 years of experience in HIV medicine, Dr. prevention among key populations through innovative Young was a Denver, Colorado-based clinician and social and behavioral interventions including stigma clinical researcher. He was Co-Principal Investigator in mitigation, economic strengthening and community the CDC HIV Outpatient Study from 1998 to 2018 and empowerment. worked in Central Asia for two years as Head of Medical Affairs for Health Connections International, a Dutch non-governmental organization. Having authored more Potential conflict of interest: than 100 peer-reviewed scientific publications, Dr. No conflict of interest to report Young has shared his HIV expertise through education programs where he has trained healthcare professionals and community groups in over 50 countries.

Dr. Young received his MD in 1992 and his PhD in Biochemistry and Molecular Biology in 1990 at the University of Colorado. He completed post-graduate training in Internal Medicine and Infectious Diseases at the University of Colorado Health Sciences Center in Denver.

Potential conflict of interest: ViiV

34 Asia-Pacific AIDS & Co-Infections Conference 2020 Program Book Acknowledgments